Cargando…
Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatmen...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012477/ https://www.ncbi.nlm.nih.gov/pubmed/35449634 http://dx.doi.org/10.7759/cureus.23226 |
_version_ | 1784687804924559360 |
---|---|
author | Munir, Farrukh Javaid, Hafiza Wajeeha Rana, Muhammad Burhan Majeed Shaukat, Fatima |
author_facet | Munir, Farrukh Javaid, Hafiza Wajeeha Rana, Muhammad Burhan Majeed Shaukat, Fatima |
author_sort | Munir, Farrukh |
collection | PubMed |
description | In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatment and patients can remain asymptomatic, frequent cell count monitoring is an essential tool to make a timely diagnosis. An appropriate drug switch, work up to rule out infection and granulocyte colony-stimulating factor (G-CSF) injection in high-risk cases is the management. The patient should be kept under observation till the resolution of agranulocytosis. We present a case of ceftriaxone-induced agranulocytosis which was completely reversible upon stoppage of drug and granulocyte colony-stimulating factor administration. The pathogenesis of ceftriaxone-induced agranulocytosis is unknown. It is suggested to occur either by an immunologic mechanism or because of direct drug toxicity. |
format | Online Article Text |
id | pubmed-9012477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-90124772022-04-20 Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis Munir, Farrukh Javaid, Hafiza Wajeeha Rana, Muhammad Burhan Majeed Shaukat, Fatima Cureus Internal Medicine In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatment and patients can remain asymptomatic, frequent cell count monitoring is an essential tool to make a timely diagnosis. An appropriate drug switch, work up to rule out infection and granulocyte colony-stimulating factor (G-CSF) injection in high-risk cases is the management. The patient should be kept under observation till the resolution of agranulocytosis. We present a case of ceftriaxone-induced agranulocytosis which was completely reversible upon stoppage of drug and granulocyte colony-stimulating factor administration. The pathogenesis of ceftriaxone-induced agranulocytosis is unknown. It is suggested to occur either by an immunologic mechanism or because of direct drug toxicity. Cureus 2022-03-16 /pmc/articles/PMC9012477/ /pubmed/35449634 http://dx.doi.org/10.7759/cureus.23226 Text en Copyright © 2022, Munir et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Munir, Farrukh Javaid, Hafiza Wajeeha Rana, Muhammad Burhan Majeed Shaukat, Fatima Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis |
title | Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis |
title_full | Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis |
title_fullStr | Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis |
title_full_unstemmed | Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis |
title_short | Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis |
title_sort | ceftriaxone-induced reversible agranulocytosis: a case report and review of drug-induced agranulocytosis |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012477/ https://www.ncbi.nlm.nih.gov/pubmed/35449634 http://dx.doi.org/10.7759/cureus.23226 |
work_keys_str_mv | AT munirfarrukh ceftriaxoneinducedreversibleagranulocytosisacasereportandreviewofdruginducedagranulocytosis AT javaidhafizawajeeha ceftriaxoneinducedreversibleagranulocytosisacasereportandreviewofdruginducedagranulocytosis AT ranamuhammadburhanmajeed ceftriaxoneinducedreversibleagranulocytosisacasereportandreviewofdruginducedagranulocytosis AT shaukatfatima ceftriaxoneinducedreversibleagranulocytosisacasereportandreviewofdruginducedagranulocytosis |